Literature DB >> 4146401

Blood-brain barrier to carbidopa (MK-486) and Ro 4-4602, peripheral dopa decarboxylase inhibitors.

W G Clark, W H Oldendorf, W G Dewherst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4146401     DOI： 10.1111/j.2042-7158.1973.tb10040.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  6 in total

1.  Striatal dopamine influences the default mode network to affect shifting between object features.

Authors:  Linh C Dang; Aneesh Donde; Cindee Madison; James P O'Neil; William J Jagust
Journal:  J Cogn Neurosci       Date:  2012-05-29       Impact factor: 3.225

2.  Genetic effects on behavior are mediated by neurotransmitters and large-scale neural networks.

Authors:  Linh C Dang; James P O'Neil; William J Jagust
Journal:  Neuroimage       Date:  2012-11-08       Impact factor: 6.556

Review 3.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man.

Authors:  R Caldara; C Barbieri; V Piepoli; M Borzio; E Masci
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

5.  The effects of carbidopa dose and time and route of administration on systemic L-dopa levels in rats.

Authors:  P S Leppert; M Cortese; J A Fix
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

6.  Crystal structure of 2,2'-oxybis(4-methylquinoline).

Authors:  Anaelle Tilborg
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.